Clinical Trial Update: Papillary Epinephrine Injection Combined With Rectal Indomethacin [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating papillary epinephrine injection combined with rectal indomethacin for post-ERCP acute pancreatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-ercp Acute Pancreatitis

Drugs mentioned

• EPINEPHRINE (EPINEPHRINE)
• Rectal Indomethacin (indomethacin)

Snippet

Sponsor: Duzce University | Conditions: Post-ERCP Acute Pancreatitis | Phase 4 | Status: COMPLETED